{"product_id":"rps6ka1-rps6ka2-rps6ka3-antibody-sc-f0506","title":"RSK1\/RSK2\/RSK3 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eRSK1\/RSK2\/RSK3 is a target of interest in many antibody-based workflows. The ribosomal S6 kinases (RSK1-4), each weighing approximately 90 kDa, constitute a family of Ser\/Thr kinases found widely across various tissues. They are characterized by possessing two distinct, yet functional, kinase domains along with a docking site for extracellular signal-regulated kinases (ERKs) at their carboxy-terminal end. Depending on the literature source, RSK1\/RSK2\/RSK3 may also be discussed as RSK1\/RSK2\/RSK3 and S6K-alpha-3.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following RSK1\/RSK2\/RSK3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eRSK1\/RSK2\/RSK3 is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm and nucleus across matched conditions\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for RSK1\/RSK2\/RSK3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in RSK1\/RSK2\/RSK3 reflect biology rather than handling. When interpreting RSK1\/RSK2\/RSK3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep RSK1\/RSK2\/RSK3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577465545049,"sku":"F0506-20UL","price":139.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577465577817,"sku":"F0506-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577465610585,"sku":"F0506-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0506-wb.gif?v=1773598553","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/rps6ka1-rps6ka2-rps6ka3-antibody-sc-f0506","provider":"Absource Diagnostics","version":"1.0","type":"link"}